IMELDA JUAREZ AVELAR



DATOS GENERALES NOMBRAMIENTOS
Nombre completo   IMELDA JUAREZ AVELAR
Máximo nivel de estudios   MAESTRÍA
Antigüedad académica en la UNAM   20 años

Vigente   TECNICO ACADEMICO TITULAR B TC Definitivo
Facultad de Estudios Superiores "Iztacala"
Desde 01-07-2019
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI C2012 - 2017
* PRIDE C2013 - 2022

INFORMACIÓN DE PUBLICACIONES
Firmas  
Juarez Avelar, Imelda Juárez I. Juarez, I Juárez-Avelar I. Juarez-Avelar, I Juarez-Avelar, Imelda
ID's SCOPUS  
56013637500 57188678927
Áreas de conocimiento  
Biochemistry & molecular biology Biochemistry and molecular biology Biology Biotechnology & applied microbiology Biotechnology and applied microbiology
Cell biology Dentistry, oral surgery and medicine Endocrinology and metabolism Immunology Infectious diseases
Integrative and complementary medicine Jcs 2008 Microbiology Parasitology Applied Microbiology and Biotechnology
Biochemistry, genetics and molecular biology (miscellaneous) Cell biology Complementary and alternative medicine Endocrinology, Diabetes and Metabolism Hematology
Immunology Immunology and Allergy Infectious Diseases Medicine (miscellaneous) Parasitology
Periodontics Spectroscopy Veterinary (miscellaneous)
Coautorías con entidades de la UNAM  
  • Instituto de Investigaciones Biomédicas
  • Instituto de Fisiología Celular
  • Facultad de Ciencias
  • Facultad de Medicina
  • Facultad de Química
  • Facultad de Medicina Veterinaria y Zootecnia
  • Facultad de Estudios Superiores "Cuautitlán"
  • Facultad de Estudios Superiores "Iztacala"
  • Facultad de Estudios Superiores "Zaragoza"
  • Dirección General de Asuntos del Personal Académico
Revistas en las que ha publicado  (19):
  1. AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, Nigeria (2017)
  2. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, Estados Unidos America (2022)
  3. BIOMED RESEARCH INTERNATIONAL, Estados Unidos America (2013)
  4. Cells, Suiza (2020)
  5. CELLULAR SIGNALLING, Estados Unidos America (2021)
  6. Cytokine, Reino Unido (2017)
  7. EUROPEAN JOURNAL OF IMMUNOLOGY, Estados Unidos America (2016)
  8. EXPERIMENTAL PARASITOLOGY, Estados Unidos America (2010, 2017)
  9. FASEB JOURNAL, Estados Unidos America (2008, 2010, 2014)
  10. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, Suiza (2022)
  11. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, Australia (2011)
  12. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Suiza (2023)
  13. J BIOMED BIOTECHNOL, Estados Unidos America (2010)
  14. JOURNAL OF DIABETES RESEARCH, Estados Unidos America (2016)
  15. JOURNAL OF IMMUNOLOGY, Estados Unidos America (2012, 2013, 2014)
  16. JOURNAL OF PERIODONTAL RESEARCH, Estados Unidos America (2024)
  17. MEDIATORS OF INFLAMMATION, Estados Unidos America (2016, 2018, 2019, 2020)
  18. MICROBES AND INFECTION, Países Bajos (2015)
  19. PARASITOLOGY RESEARCH, Estados Unidos America (2018)


Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Rista Fuente Citas WoS Citas Scopus
1Periodontitis exacerbation during pregnancy in mice: Role of macrophage migration inhibitory factor as a key inductor2ᵒ autor: Juárez-Avelar I., Ortiz-Sánchez B.J., Andrade-Meza A., Mendoza-Rodríguez M.G., et al.2024JOURNAL OF PERIODONTAL RESEARCHWoS-id: 001105641100001
Scopus-id: 2-s2.0-85177462728
00
2Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative TherapiesCoautor: Juarez-Avelar, Imelda, Andrade-Meza, Antonio, Arias-Romero, Luis E., Armas-Lopez, Leonel, et al.2023INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESWoS-id: 000930241500001
Scopus-id: 2-s2.0-85147894672
11
3Macrophage migration inhibitory factor contributes to immunopathogenesis during Plasmodium yoelii 17XL infection2ᵒ autor: Juarez-Avelar, Imelda, Salazar-Castanon, Victor H., Legorreta-Herrera, Martha, Rodriguez-Sosa, Miriam2022FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGYWoS-id: 000850730400001
Scopus-id: 2-s2.0-85137671882
11
4Dual activation profile of monocytes is associated with protection in Mexican patients during SARS-CoV-2 diseaseCoautor: Juarez-Avelar, Imelda, Acosta-Altamirano, Gustavo, Garduño-Javier E., Hernandez-Gomez, Victoria, et al.2022APPLIED MICROBIOLOGY AND BIOTECHNOLOGYWoS-id: 000879724300001
Scopus-id: 2-s2.0-85141422672
11
5Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarizationCoautor: Juarez-Avelar, Imelda, Cotzomi-Ortega, Israel, Nieto-Yanez, Oscar, Rojas-Sanchez, Guadalupe, et al.2021CELLULAR SIGNALLINGWoS-id: 000689714600007
Scopus-id: 2-s2.0-85111786823
1323
6MGL1 Receptor Plays a Key Role in the Control of T. cruzi Infection by Increasing Macrophage Activation through Modulation of ERK1/2, c-Jun, NF-kappa B and NLRP3 PathwaysCoautor: Juarez-Avelar, Imelda, Rodriguez, Tonathiu, Pacheco-Fernandez, Thalia, Vazquez-Mendoza, Alicia, et al.2020CellsWoS-id: 000515398200108
Scopus-id: 2-s2.0-85100125067
98
7Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer (vol 2019, 2056085, 2019)2ᵒ autor: Juarez-Avelar, Imelda, Pacheco-Fernandez, Thalia, Illescas, Oscar, Terrazas, Luis I., et al.2020MEDIATORS OF INFLAMMATIONWoS-id: 000546137100001
Scopus-id: 2-s2.0-85087901967
11
8Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer2ᵒ autor: Juarez-Avelar, Imelda, Pacheco-Fernandez, Thalia, Illescas, Oscar, Terrazas, Luis I., et al.2019MEDIATORS OF INFLAMMATIONWoS-id: 000476777800001
Scopus-id: 2-s2.0-85070837516
1517
9Co-infection: the outcome of Plasmodium infection differs according to the time of pre-existing helminth infection2ᵒ autor: Juárez-Avelar I., Salazar-Castañón V.H., Legorreta-Herrera M., Govezensky T., et al.2018PARASITOLOGY RESEARCHWoS-id: 000442501900007
Scopus-id: 2-s2.0-85048975329
78
10Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye DiseaseCoautor: Juarez Avelar, Imelda, Reyes J.L., Vannan D.T., Eksteen B., et al.2018MEDIATORS OF INFLAMMATIONWoS-id: 000442883000001
Scopus-id: 2-s2.0-85057243203
2936
11Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial functionCoautor: Juárez-Avelar I., Rodriguez-Sosa M., Cabellos-Avelar T., Sanchez-Zamora Y., et al.2017CytokineWoS-id: 000416186500028
Scopus-id: 2-s2.0-85026661998
710
12Type 2 diabetes mellitus BALB/c mice are more susceptible to granulomatous amoebic encephalitis: Immunohistochemical studyCoautor: Juarez-Avelar I., Omana-Molina, Maritza, Sanchez-Rocha R., Hernandez-Martinez D., et al.2017EXPERIMENTAL PARASITOLOGYWoS-id: 000418107300024
Scopus-id: 2-s2.0-85030715320
89
13IN VIVO AND IN VITRO ANTILEISHMANIAL EFFECTS OF METHANOLIC EXTRACT FROM BARK OF BURSERA APTERACoautor: Juarez-Avelar I., Nieto-Yañez O.J., Resendiz-Albor A.A., Ruiz-Hurtado P.A., et al.2017AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINESScopus-id: 2-s2.0-85027490425
05
14MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine ToxoplasmosisCoautor: Juarez-Avelar, Imelda, de Dios Ruiz-Rosado, Juan, Olguin, Jonadab E., Saavedra, Rafael, et al.2016MEDIATORS OF INFLAMMATIONWoS-id: 000372275900001
Scopus-id: 2-s2.0-84962217296
1725
15MIF promotes classical activation and conversion of inflammatory Ly6C(high) monocytes into Tip-DCs during murine toxoplasmosisCoautor: Juarez-Avelar, I, Ruiz-Rosado, J. D. D., Olguin, J. E., Saavedra, R., et al.2016EUROPEAN JOURNAL OF IMMUNOLOGYWoS-id: 000383610401517
00
16Altered Macrophage and Dendritic Cell Response in Mif -/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes2ᵒ autor: Juarez-Avelar, Imelda, Itzel Sanchez-Zamora, Yuriko, Vazquez-Mendoza, Alicia, Hiriart, Marcia, et al.2016JOURNAL OF DIABETES RESEARCHWoS-id: 000383632800001
Scopus-id: 2-s2.0-84988710072
1519
17Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated T(h)1 immune responseCoautor: Juarez, I, Olguin, JE, Fernandez, J, Salinas, N, et al.2015MICROBES AND INFECTIONWoS-id: 000358804300008
Scopus-id: 2-s2.0-84944358193
1618
18Macrophage migration inhibitory factor has a role in controlling colorectal cancerCoautor: Juarez-Avelar, Imelda, Rodriguez-Sosa, Miriam, Pacheco-Fernandez, Thalia, Chirino, Yolanda, et al.2014JOURNAL OF IMMUNOLOGYWoS-id: 000209765004058
00
19Macrophage migration inhibitory factor has a role controlling colorectal cancerCoautor: Juarez-Avelar, I, Rodriguez-Sosa, M, Pacheco-Fernandez, T, Rodriguez-Monroy, M, et al.2014FASEB JOURNALWoS-id: 000346651004432
00
20Taenia crassiceps Infection Does Not Infuence the Development of Experimental Rheumatoid ArthritisCoautor: Juarez, I, "Ortiz-Flores, AM, Ledesma-Soto, Y, Calleja, EA, et al.2013BIOMED RESEARCH INTERNATIONALWoS-id: 000314938800001
Scopus-id: 2-s2.0-84874636676
77
21Macrophage migration inhibitory factor plays a role in the maturation of conventional dendritic cells in acute Toxoplasma gondii infectionCoautor: Juarez-Avelar, I, Rodriguez-Sosa, M, Hernandez-Hernandez, FDL, Calixto, CG, et al.2013JOURNAL OF IMMUNOLOGYWoS-id: 000322987102231
00
22Mouse macrophage galactosa-type lectin (mMGL) is critical for the host resistance against Trypanosoma cruzi infectionCoautor: Juarez, I, Rodriguez-Sosa, M, Vazquez, A, Gomez-Garcia, L, et al.2012JOURNAL OF IMMUNOLOGYWoS-id: 000304659700353
00
23MIF Synergizes with Trypanosoma cruzi Antigens to Promote Efficient Dendritic Cell Maturation and IL-12 Production via p38 MAPKCoautor: Juarez, I, Terrazas, CA, Huitron, E, Vazquez, A, et al.2011INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCESWoS-id: 000298011000008
Scopus-id: 2-s2.0-81255189056
2526
24The Unexpected Role for the Aryl Hydrocarbon Receptor on Susceptibility to Experimental ToxoplasmosisCoautor: Juarez, I, Sanchez, Y, Rosado, JD, Vega, L, et al.2010J BIOMED BIOTECHNOLWoS-id: 000275081500001
Scopus-id: 2-s2.0-77950366780
3746
25Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitusCoautor: Juárez I., Sanchez-Zamora Y., Terrazas L.I., Vilches-Flores A., et al.2010FASEB JOURNALWoS-id: 000279343600045
Scopus-id: 2-s2.0-77954453333
4549
26Toxoplasma gondii: Impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection2ᵒ autor: Juarez, I, Terrazas, CA, Terrazas, LI, Saavedra, R, et al.2010EXPERIMENTAL PARASITOLOGYWoS-id: 000281938200011
Scopus-id: 2-s2.0-77956234775
2730
27Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondiiCoautor: Juárez I., Flores M., Saavedra R., Bautista R., et al.2008FASEB JOURNALWoS-id: 000259642600027
Scopus-id: 2-s2.0-54049155727
5662

Capítulos de libros (WoS y Scopus)

# Título del capítulo Título del libro Autores Alcance Año ISBN Fuente
1Macrophage migration inhibitory factor (MIF): Its role in the genesis and progression of colorectal cancerImmunotherapy In Resistant Cancer: From The Lab Bench Work To Its Clinical PerspectivesJuárez-Avelar I., Rodríguez T., Rodríguez-Sosa M., et al.Capítulo de un Libro20209780128220283Scopus-id: 2-s2.0-85147600526

Proyectos

# Nombre Participantes Convocatoria Fecha Inicio Fecha Fin
1Estudio de la participación de MIF en el desarrollo y establecimiento del cáncer colorrectal asociado a colitis en un modelo murino.IMELDA JUAREZ AVELAR,
Sector Pblico (Federal, Estatal o Municipal)01-01-202301-09-2024

Descargar PDF